ClinicalTrials.Veeva

Menu

Infant-parent Skin-to-skin Contact During Screening for Retinopathy

S

St. Olavs Hospital

Status

Completed

Conditions

Retinopathy of Prematurity

Treatments

Behavioral: skin-to-skin contact
Device: incubator
Drug: Sucrose

Study type

Interventional

Funder types

Other

Identifiers

NCT02780544
2011/2532b

Details and patient eligibility

About

Retinopathy of prematurity (ROP) is a feared complication of premature birth. If discovered in time, the disease can be treated, and impaired vision or blindness can be reduced. Premature infants are therefore examined regularly after birth. However, the examination is painful and stressful for the infant. Painful experiences might lead to a pathological stress response later in life and should therefore be prevented.

In this study skin-to-skin contact with a parent is tested for relief of pain and stress in preterm infants being examined for retinopathy of prematurity.

Enrollment

34 patients

Sex

All

Ages

31 to 37 weeks old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Infants < 32 weeks of gestational age (< 31+6 weeks)

Exclusion criteria

  • Infants with ongoing analgesic treatment

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

34 participants in 2 patient groups

skin-to-skin contact + sucrose
Experimental group
Description:
the infants get 2 eye examinations within 1 week in randomized order, one in skin-to-skin position with a parent (intervention group) and one in the incubator (standard care). Sucrose (0.2 ml) lingual will be given for pain relief according to standard care two minutes before either eye examination.
Treatment:
Drug: Sucrose
Behavioral: skin-to-skin contact
incubator + sucrose
Active Comparator group
Description:
the infants get 2 eye examinations within 1 week in randomized order, one in the incubator (standard care) and one in skin-to-skin position with a parent (intervention group). Sucrose (0.2 ml) lingual will be given for pain relief according to standard care two minutes before either eye examination
Treatment:
Device: incubator
Drug: Sucrose

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems